220 related articles for article (PubMed ID: 34683891)
1. Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening.
Aguiar SI; Dias JNR; André AS; Silva ML; Martins D; Carrapiço B; Castanho M; Carriço J; Cavaco M; Gaspar MM; Nobre RJ; Pereira de Almeida L; Oliveira S; Gano L; Correia JDG; Barbas C; Gonçalves J; Neves V; Aires-da-Silva F
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683891
[TBL] [Abstract][Full Text] [Related]
2. Single domain antibody-based vectors in the delivery of biologics across the blood-brain barrier: a review.
Gao Y; Zhu J; Lu H
Drug Deliv Transl Res; 2021 Oct; 11(5):1818-1828. PubMed ID: 33155179
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1.
Stocki P; Szary J; Rasmussen CLM; Demydchuk M; Northall L; Logan DB; Gauhar A; Thei L; Moos T; Walsh FS; Rutkowski JL
FASEB J; 2021 Feb; 35(2):e21172. PubMed ID: 33241587
[TBL] [Abstract][Full Text] [Related]
4.
André AS; Moutinho I; Dias JNR; Aires-da-Silva F
Front Microbiol; 2022; 13():962124. PubMed ID: 36225354
[TBL] [Abstract][Full Text] [Related]
5. Brain Delivery of IGF1R5, a Single-Domain Antibody Targeting Insulin-like Growth Factor-1 Receptor.
Yogi A; Hussack G; van Faassen H; Haqqani AS; Delaney CE; Brunette E; Sandhu JK; Hewitt M; Sulea T; Kemmerich K; Stanimirovic DB
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890347
[TBL] [Abstract][Full Text] [Related]
6. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
7. Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.
Comor L; Dolinska S; Bhide K; Pulzova L; Jiménez-Munguía I; Bencurova E; Flachbartova Z; Potocnakova L; Kanova E; Bhide M
Microb Cell Fact; 2017 Jan; 16(1):13. PubMed ID: 28114943
[TBL] [Abstract][Full Text] [Related]
8. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
[TBL] [Abstract][Full Text] [Related]
9. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system.
Thom G; Hatcher J; Hearn A; Paterson J; Rodrigo N; Beljean A; Gurrell I; Webster C
MAbs; 2018; 10(2):304-314. PubMed ID: 29182455
[TBL] [Abstract][Full Text] [Related]
10. A novel in vivo method for isolating antibodies from a phage display library by neuronal retrograde transport selectively yields antibodies against p75(NTR.).
Tani H; Osbourn JK; Walker EH; Rush RA; Ferguson IA
MAbs; 2013; 5(3):471-8. PubMed ID: 23549155
[TBL] [Abstract][Full Text] [Related]
11. Selection of human single domain antibodies (sdAb) against thymidine kinase 1 and their incorporation into sdAb-Fc antibody constructs for potential use in cancer therapy.
Velazquez EJ; Cress JD; Humpherys TB; Mortimer TO; Bellini DM; Skidmore JR; Smith KR; Robison RA; Weber SK; O'Neill KL
PLoS One; 2022; 17(3):e0264822. PubMed ID: 35239730
[TBL] [Abstract][Full Text] [Related]
12. Identifying blood-brain-barrier selective single-chain antibody fragments.
Jones AR; Stutz CC; Zhou Y; Marks JD; Shusta EV
Biotechnol J; 2014 May; 9(5):664-74. PubMed ID: 24644233
[TBL] [Abstract][Full Text] [Related]
13. Getting into the brain: approaches to enhance brain drug delivery.
Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
15. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
16. Rabbit derived VL single-domains as promising scaffolds to generate antibody-drug conjugates.
André AS; Dias JNR; Aguiar S; Nogueira S; Bule P; Carvalho JI; António JPM; Cavaco M; Neves V; Oliveira S; Vicente G; Carrapiço B; Braz BS; Rütgen B; Gano L; Correia JDG; Castanho M; Goncalves J; Gois PMP; Gil S; Tavares L; Aires-da-Silva F
Sci Rep; 2023 Mar; 13(1):4837. PubMed ID: 36964198
[TBL] [Abstract][Full Text] [Related]
17. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
[TBL] [Abstract][Full Text] [Related]
19. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.
Pardridge WM
Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
